BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2017
View Archived Issues
Cytovation raises funds to advance CyPep-1
Read More
Ultupharma divulges novel antibacterials
Read More
Sunshine Lake Pharma presents novel RNA-directed RNA polymerase inhibitors
Read More
Phase I/II data on EPI-506 presented for the treatment of mCRPC
Read More
FDA grants orphan drug designation for ALM-201 for the treatment of ovarian cancer
Read More
Celgene's CC-220 shows promise in phase II SLE study
Read More
Bayer initiates phase III ASTEROID study program of vilaprisan
Read More
Pralia approved for additional indication in Japan
Read More
Novartis files application in Japan to expand approval of Signifor
Read More
Vanucizumab trial suggests ANG-2 is not a relevant target in metastatic colorectal cancer
Read More
Swedish Orphan Biovitrum's SOBI-003 receives U.S. orphan status for MPS type III A
Read More
FDA grants glasdegib orphan designation for acute myeloid leukemia
Read More
Phase I data presented for AMG-232 in metastatic cutaneous melanoma
Read More
Novartis' Jadenu approved in Japan
Read More
Synspira raises funds to advance cystic fibrosis candidate into clinic
Read More
Angle reports topline data from Parsortix pelvic mass studies
Read More
Acer Therapeutics enters merger agreement with Opexa Therapeutics
Read More
Mitsubishi Tanabe Pharma obtains approval in Japan for Canalia combination tablets
Read More
Human neural stem cells show disease-modifying activity in Huntington's disease model
Read More
Antisense oligonucleotide QRX-411 named FDA orphan drug for retinitis pigmentosa
Read More
Spanish antitrust approval for Norgine's acquisition of Merus Labs
Read More
SOX4 found to be a poor prognostic marker in acute myeloid leukemia
Read More
Japan's MHLW approves Olumiant for rheumatoid arthritis
Read More